The Breakthrough: Immunotherapy and the Race to Cure Cancer
| Industry | Publishing |
|---|---|
| Headquarters | United States |
| Products | Books |
The Breakthrough: Immunotherapy and the Race to Cure Cancer is a nonfiction work authored by American journalist Charles Graeber. Aimed at a broad readership, it explores the field of immunology alongside the progress made in cancer immunotherapy. Released by Twelve shortly before James P. Allison and Tasuku Honjo were awarded the 2018 Nobel Prize in Physiology or Medicine for their contributions to cancer immunology, the book emphasizes significant milestones within this area of research.
Backstory
Initially, Graeber’s literary agent expressed doubts about the project due to reservations voiced by a retired oncologist but eventually gave their support. The writing process proved demanding, requiring four years of investigation to effectively merge captivating storytelling with an in-depth examination of the development of cancer immunotherapy.
Synopsis
This volume follows the history of cancer immunotherapy beginning with William Coley’s toxin-based treatments in the 1890s, through periods marked by slow advancement, up to recent approvals of immune checkpoint inhibitors such as CTLA-4, PD-1, and PD-L1, along with CAR T cell therapies. It places these scientific breakthroughs within the wider context of both research and commercial efforts, highlighting influential figures including Nobel Prize winners Allison and Honjo.
Reception
The Breakthrough garnered favorable critiques from prominent media outlets. Barbara Kiser, writing for Nature, described it as a "skillful, thorough analysis" that brings pioneering researchers to life. The New York Times commended Graeber’s adept chronicling of immunotherapy’s progression toward a possible cure for cancer. The Wall Street Journal found it "captivating" and emotionally impactful, while the Winnipeg Free Press praised it as "masterfully crafted" and consistently engaging.
Awards
The book was named a finalist for the 2019 Medical Book of the Year award by the British Medical Association.